| 摘要 |
N-acyl-N,N min -di-lysogangliosides, N min -acyl-N,N min -di-lysogangliosides and N,N min -diacyl-N,N min -di-lysogangliosides, wherein the acyl groups are derived from an aliphatic acid having from 1 to 24 carbon atoms, substituted by one or more polar groups. The acyl-di-lysogangliosides of the invention exhibit an inhibiting action on protein kinase C activation and, thus, can be utilized in therapies for various pathologies of the nervous system. Pharmaceutical compositions and therapeutic utilities for the lysoganglioside derivatives are also disclosed. |
